Welcome to the latest episode of the Full-Court Finance podcast from Zacks Investment Research where Associate Stock Strategist Ben Rains breaks down the NFL’s recently released 2018 regular season TV ratings, which bounced back after years of declines. The episode then dives into how the NFL’s new partnership with Caesars Entertainment CZR stacks up against MGM’s MGM deals with the NBA and other leagues and discusses why they mean so much.
The NFL’s ratings jumped 5% during the 2018 regular season. The reasons for the climb in TV viewership from 2017 are up for debate. But in the age of Netflix NFLX and Amazon AMZN, it seems that the NFL is poised to remain a juggernaut that advertisers must pay top dollar for.
The NFL’s national TV ratings climbed across the board, with all of its TV partners’ ratings—Fox FOXA, CBS CBS, NBC CMCSA, and ESPN DIS—up from last year. NBC’s Sunday Night Football remained king, but Disney was likely pleased to see Monday Night Football’s ratings surge 8%. Other TV-based stats also helped prove that the NFL remains a force and should help keep its biggest marketing and advertising partners, which include Nike NKE, PepsiCo PEP, Anheuser Busch InBev BUD, Ford F, Microsoft MSFT, Pizza Hut YUM, and others, around for years to come.
Meanwhile, the NFL also announced late last week that it signed a deal with Caesars that will see it become the first-ever “Official Casino Sponsor of the NFL.” The deal comes after the three other major North American professional sports leagues signed partnerships with MGM. But the NFL’s deal is certainly unique, expensive, and highlights differences from its counterparts.
Going forward, the NFL must try to grow in the new age of entrainment as it eases its way into the potentially game-changing world of legalized sports gambling. The notoriously old-school and strict NFL also has to attract younger, YouTube GOOGL and Instagram FB obsessed fans. And it certainly seems that the most popular sports league in the U.S. is trying to adapt in order to continue its dominance.
As a reminder, if you feel that we missed something, or if you have any topic suggestions, shoot us an email at email@example.com. Make sure to check out all of our other audio content at zacks.com/podcasts, and remember to subscribe and leave us a rating wherever you listen to your podcasts.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MGM Resorts International (MGM) : Free Stock Analysis Report
Caesars Entertainment Corporation (CZR) : Free Stock Analysis Report
CBS Corporation (CBS) : Free Stock Analysis Report
The Walt Disney Company (DIS) : Free Stock Analysis Report
Netflix, Inc. (NFLX) : Free Stock Analysis Report
Amazon.com, Inc. (AMZN) : Free Stock Analysis Report
Facebook, Inc. (FB) : Free Stock Analysis Report
Alphabet Inc. (GOOGL) : Free Stock Analysis Report
Ford Motor Company (F) : Free Stock Analysis Report
Anheuser-Busch InBev SA/NV (BUD) : Free Stock Analysis Report
Pepsico, Inc. (PEP) : Free Stock Analysis Report
Comcast Corporation (CMCSA) : Free Stock Analysis Report
Microsoft Corporation (MSFT) : Free Stock Analysis Report
Twenty-First Century Fox, Inc. (FOXA) : Free Stock Analysis Report
Yum! Brands, Inc. (YUM) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research